CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 32 enrolled
Drug / intervention
Preventive Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03546491
NCT03546491Phase 3Completed
CompareCT.gov

A Clinical Study to Evaluate Anti-Plaque Benefit of a Gel in a Modified- 4 Day Plaque Model

Procter and Gamble·interventional·Posted Jun 6, 2018·Updated Sep 4, 2019

In Brief

A Phase 3 clinical trial evaluating Preventive Gel and Marketed Control for Dental Plaque. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Plaque
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedJun 6, 2018
Enrollment StartMay 8, 2018
Primary CompletionJun 22, 2018
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 8.1 years ago

Interventions

Preventive Geldrug

0.4% Stannous Fluoride

Marketed Controldrug

0.243% Sodium Fluoride